These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Prospective Analysis of Potential and Observed Drug-Drug Interactions, Adverse Events and its Associated Risk Factors in Hospitalized Cardiology Patients in Benin. Allabi ACE, Tchabi Y, Hounkponou M, Quenum R, Vehounkpe-Sacca J. Curr Drug Saf; 2020; 15(3):190-197. PubMed ID: 32564759 [Abstract] [Full Text] [Related]
3. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital. Ramasubbu SK, Mahato SK, Agnihotri A, Pasricha RK, Nath UK, Das B. Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276 [Abstract] [Full Text] [Related]
4. Drug-drug interactions in hospitalized cardiac patients. Mateti U, Rajakannan T, Nekkanti H, Rajesh V, Mallaysamy S, Ramachandran P. J Young Pharm; 2011 Oct; 3(4):329-33. PubMed ID: 22224041 [Abstract] [Full Text] [Related]
5. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items. Kovačević M, Vezmar Kovačević S, Radovanović S, Stevanović P, Miljković B. Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967 [Abstract] [Full Text] [Related]
8. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil. Castilho ECD, Reis AMM, Borges TL, Siqueira LDC, Miasso AI. J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271 [Abstract] [Full Text] [Related]
9. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis. Gonzaga de Andrade Santos TN, Mendonça da Cruz Macieira G, Cardoso Sodré Alves BM, Onozato T, Cunha Cardoso G, Ferreira Nascimento MT, Saquete Martins-Filho PR, Pereira de Lyra D, Oliveira Filho AD. PLoS One; 2020 Feb; 15(7):e0235353. PubMed ID: 32609783 [Abstract] [Full Text] [Related]
13. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors. Fernández de Palencia Espinosa MÁ, Díaz Carrasco MS, Alonso Romero JL, de la Rubia Nieto A, Espuny Miró A. Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788 [Abstract] [Full Text] [Related]
14. Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis. Dechanont S, Maphanta S, Butthum B, Kongkaew C. Pharmacoepidemiol Drug Saf; 2014 May; 23(5):489-97. PubMed ID: 24616171 [Abstract] [Full Text] [Related]
16. Clinical relevance of drug-drug interactions in hospitalized dermatology patients. Ganeva M, Gancheva T, Troeva J, Kiriyak N, Hristakieva E. Adv Clin Exp Med; 2013 May; 22(4):555-63. PubMed ID: 23986216 [Abstract] [Full Text] [Related]
17. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Doan J, Zakrzewski-Jakubiak H, Roy J, Turgeon J, Tannenbaum C. Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734 [Abstract] [Full Text] [Related]